PHA767491 HCl

CAS No. 942425-68-5

PHA767491 HCl( CAY-10572 hydrochloride )

Catalog No. M19277 CAS No. 942425-68-5

PHA-767491 is an effective ATP-competitive dual Cdc7/CDK9 inhibitor (IC50: 10/34 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 46 In Stock
5MG 41 In Stock
10MG 58 In Stock
25MG 93 In Stock
50MG 133 In Stock
100MG 219 In Stock
200MG 324 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PHA767491 HCl
  • Note
    Research use only, not for human use.
  • Brief Description
    PHA-767491 is an effective ATP-competitive dual Cdc7/CDK9 inhibitor (IC50: 10/34 nM).
  • Description
    PHA-767491 is an effective ATP-competitive dual Cdc7/CDK9 inhibitor (IC50: 10/34 nM). It has ~20-fold selectivity against GSK3-β and CDK1/2, 50-fold selectivity against CDK5 and MK2, 100-fold selectivity against CHK2 and PLK1.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CAY-10572 hydrochloride
  • Pathway
    Endocrinology/Hormones
  • Target
    Reductase
  • Recptor
    Cdk1| Cdk2| Cdk9| Cdc7| GSK-3β
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    942425-68-5
  • Formula Weight
    213.24
  • Molecular Formula
    C12H11N3O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 17.33 mg/mL 69.40 mM
  • SMILES
    Cl.O=C1NCCc2nc(cc12)c3ccncc3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Montagnoli A, et al. Nat Chem Biol, 2008, 4(6), 357-365.
molnova catalog
related products
  • Zopolrestat

    Zopolrestat is a potent inhibitor of aldose reductase (IC50 = 3.1 nM).

  • Alconil

    Alconil (Al 1567) is an aldose reductase inhibitor that may be used to study chronic obstructive pulmonary disease (COPD) and diabetes.

  • Sorbinil

    Sorbinil is an Aldose reductase inhibitor. Sorbinil plays a therapeutic role in treating diabetes and diabetic complications decreases AR activity and inhibit the polyol pathway.